Clinical trial
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
NCT04504188 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
- Lead sponsor
- Zoll Medical Corporation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 8, 2021
- Completion date
- December 31, 2024
- Enrollment
- 300 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.